EUVIMEDEUVIMED entdecken
Open Access

METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy

Chunyan Wang iD, Siman Shen, Jiayi Kang, Aya Sugai-Munson, Xiao Xiao iD, Yajing Zhang iD, Junyuan Zhu, Zipeng Liu, Tina B McKay, Oluwaseun Akeju iD, Eric R Jonas iD, Amrut V Ambardekar iD und 3 weitere

Circulation · 05.08.2025 · 152 (5) · 327-345

DOI: 10.1161/circulationaha.124.070279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 05.08.2025. Verfasst von Chunyan Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston (C.W., S.S., J.K., A.S.-M., X.X., Y.Z., J.Z., T.B.…. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Methyltransferases, Physical Conditioning, Animal. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Exercise improves functional outcomes in patients with diabetic cardiomyopathy (DiaCM). The molecular mechanism underlying cardiac benefits of exercise in DiaCM remains incompletely understood. N6-methyladenosine (m6A) is the most common form of messenger RNA modification in eukaryotes and has been implicated in cardiac development and disease. However, the role of m6A in DiaCM and in the mitigating effects of exercise on this disease are unclear. METHODS: Cardiomyocyte-specific N6-adenosine-methyltransferase-like 3 (METTL3, an m6A methyltransferase) knockout mice and their wild-type littermates were subjected to either chow diet or high-fat diet feeding and injection of streptozotocin to induce DiaCM, followed by an 8-week exercise training and assessment of cardiac function. Some of the mice were injected with adeno-associated viral vector encoding METTL3 to overexpress METTL3 in cardiomyocytes. Cardiac METTL3 expressions were assessed in patients with nonischemic primary dilated cardiomyopathies without or with diabetes. Potential METTL3 downstream effector YBX1 (Y-box binding protein 1) was identified through RNA sequencing. The functional role of YBX1 was examined through adeno-associated viral vector overexpression or knockdown in cardiomyocytes in DiaCM mice. RESULTS: We showed that cardiac METTL3 protein expression and m6A level were downregulated in patient with dilated cardiomyopathy and further downregulated in patients with dilated cardiomyopathy and diabetes. Consistently, cardiac METTL3 and m6A were downregulated in mouse with DiaCM, whereas they were upregulated by exercise. Cardiomyocyte-specific METTL3 knockout eliminated the cardiac benefits of exercise on DiaCM. Conversely, cardiomyocyte-specific METTL3 overexpression improved systolic and diastolic function in 2 DiaCM mouse models. We demonstrated that exercise enhanced cardiac METTL3 expression in DiaCM through signal transducer and activator of transcription 3. Moreover, METTL3 attenuated DiaCM through m6A-depdendent YBX1 upregulation and the subsequent activation of Nrf2. Cardiomyocyte-specific YBX1 overexpression promoted Nrf2 activation and attenuated oxidative stress, resulting in an improvement in cardiac function in DiaCM. In contrast, cardiomyocyte-specific YBX1 gene knockdown abolished the effect of METTL3 on cardiac improvement in mice with DiaCM. Further, pharmacological activation of METTL3 using a small molecule attenuated cardiac dysfunction in DiaCM. CONCLUSIONS: These studies reveal an essential role of METTL3 in the cardiac benefits of exercise and identify METTL3 and YBX1 as promising therapeutic targets for treating DiaCM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic CardiomyopathiesMethyltransferasesPhysical Conditioning, AnimalAnimalsHumansMice, KnockoutMiceMaleMyocytes, CardiacMice, Inbred C57BLDiabetes Mellitus, Experimental

Stichwörter der Autor:innen

N(6)-methyladenosineRNA methylationdiabetic cardiomyopathiesexerciseheart failureoxidative stress

Substanzen

MethyltransferasesMettl3 protein, mouseMETTL3 protein, human

Autor:innen und Institutionen

  • Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital, Boston (C.W., S.S., J.K., A.S.-M., X.X., Y.Z., J.Z., T.B.M., O.A., H.L.).
  • Harvard Medical School, Boston, MA (Y.Z., T.B.M., O.A., H.L.).
  • Institute of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, China (Z.L.).
  • Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora (E.R.J., A.V.A., M.R.B.).
  • Department of Anesthesiology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China (W.Y.).

ORCID-Profile: Chunyan Wang, Xiao Xiao, Yajing Zhang, Oluwaseun Akeju, Eric R Jonas, Amrut V Ambardekar, Michael R Bristow, Haobo Li

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Wang, C., Shen, S., Kang, J., Sugai-Munson, A., Xiao, X., Zhang, Y., Zhu, J., Liu, Z., McKay, T. B., Akeju, O., Jonas, E. R., Ambardekar, A. V., Bristow, M. R., Yao, W., & Li, H. (2025). METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy. Circulation, 152(5), 327-345. https://doi.org/10.1161/circulationaha.124.070279

Vancouver

Wang C, Shen S, Kang J, Sugai-Munson A, Xiao X, Zhang Y, et al. METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy. Circulation. 2025;152(5):327-345. doi:10.1161/circulationaha.124.070279

BibTeX
@article{Wang2025,
  author = {Wang, Chunyan and Shen, Siman and Kang, Jiayi and Sugai-Munson, Aya and Xiao, Xiao and Zhang, Yajing and Zhu, Junyuan and Liu, Zipeng and McKay, Tina B and Akeju, Oluwaseun and Jonas, Eric R and Ambardekar, Amrut V and Bristow, Michael R and Yao, Weifeng and Li, Haobo},
  title = {METTL3 Is Essential for Exercise Benefits in Diabetic Cardiomyopathy},
  journal = {Circulation},
  year = {2025},
  volume = {152},
  number = {5},
  pages = {327--345},
  doi = {10.1161/circulationaha.124.070279}
}
Kostenlos starten →